Myeloablative versus non-myeloablative consolidative chemotherapy for newly diagnosed primary central nervous system lymphoma: Results of CALGB 51101 (Alliance).

被引：21

作者：

Batchelor, Tracy

Giri, Sharmila

Ruppert, Amy S.

Bartlett, Nancy L.

Hsi, Eric D.

Cheson, Bruce D.

Nayak, Lakshmi

Leonard, John Paul

Rubenstein, James L.

机构：

[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA

[2] Mayo Clin, Rochester, MN USA

[3] Alliance Stat & Data Ctr, Columbus, OH USA

[4] Washington Univ, Sch Med, St Louis, MO 63110 USA

[5] Siteman Canc Ctr, St Louis, MO USA

[6] Wake Forest Univ Hlth Sci, Winston Salem, NC USA

[7] Lymphoma Res Fdn, Washington, DC USA

[8] Dana Farber Canc Inst, Boston, MA 02115 USA

[9] New York Presbyterian Hosp, Weill Cornell Med Coll, Meyer Canc Ctr, New York, NY USA

[10] Univ Calif San Francisco, San Francisco, CA 94143 USA

来源：

基金：

美国国家卫生研究院;

关键词：

D O I：

10.1200/JCO.2021.39.15_suppl.7506

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

7506

引用

页数：3